Cambridge Associates Portfolio holdings
Cambridge Associates, founded in 1973 by Harvard College roommates Hunter Lewis and James Bailey, builds portfolios for endowments, foundations, pension plans, healthcare systems and private clients. It started out selling investment research to endowments and foundations before moving into investment consulting and portfolio management. Clients can hand over investment decisions entirely, with Cambridge Associates acting as their outsourced investment office, or keep their own staff and use the firm for advice on asset allocation and manager selection. It also manages portfolios focused on a single area, such as private equity, hedge funds, real assets and private credit.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$54.4M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$46M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$21.6M |
| 4 |
Vanguard Russell 1000 Value ETF
VONV
|
+$20.3M |
| 5 |
State Street SPDR Portfolio Intermediate Term Treasury Index ETF
SPTI
|
+$14.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$105M |
| 2 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$83.8M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$50.7M |
| 4 |
Vanguard Dividend Appreciation ETF
VIG
|
+$34.7M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 99.97% |
| 2 | Industrials | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LYNX
51
Lyntris
LYNX
$1.57B
| $1.79M | 0.03% |
+145,237
| New | +$1.96M |
2026 Q3
0 quarters
|
|
52
iShares Bitcoin Trust
IBIT
$55.2B
| $1.4M | 0.02% |
29,497
| – | – |
2025 Q4
3 quarters
|
|
53
iShares Russell Mid-Cap ETF
IWR
$58.3B
| $1.3M | 0.02% |
12,198
| – | – |
2025 Q3
4 quarters
|
|
54
VanEck Israel ETF
ISRA
$145M
| $1.04M | 0.02% |
15,615
| – | – |
2018 Q4
31 quarters
|
|
55
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.33B
| $663K | 0.01% |
14,033
| – | – |
2023 Q4
11 quarters
|
|
56
iShares S&P 500 Growth ETF
IVW
$73.4B
| $214K | ﹤0.01% |
+1,507
| New | +$209K |
2026 Q3
0 quarters
|
|
57
iShares MSCI Canada ETF
EWC
$7.53B
| – | – |
-9,471
| Closed | -$546K | – |
|
58
GMO US Quality ETF
QLTY
$5.56B
| – | – |
-148,114
| Closed | -$6.16M | – |
|
|
59
Vanguard Dividend Appreciation ETF
VIG
$118B
| – | – |
-146,581
| Closed | -$34.7M | – |
|
60
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| – | – |
-19,968
| Closed | -$1.61M | – |
|
61
Karman Holdings
KRMN
$5.39B
| – | – |
-68,493
| Closed | -$3.42M | – |
|
Similar funds
Cambridge Associates's Q3 2026 Portfolio in Review
As of Q3 2026, Cambridge Associates held 61 positions worth $6.78B, down 2.2% from $6.93B the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Cambridge Associates's Q3 2026 filing shows 5 new, 16 increased, 18 reduced and 5 closed positions. Its largest new stake was State Street SPDR Portfolio Intermediate Term Treasury Index ETF: 531,824 shares worth $14.5M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $105M.
By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, up from 100% a quarter earlier, followed by Industrials.
- Cambridge Associates's largest Q3 2026 buy was State Street SPDR Portfolio Intermediate Term Treasury Index ETF: 531,824 shares worth $14.5M.
- Cambridge Associates added most to iShares Core MSCI EAFE ETF in Q3 2026, an estimated $54.4M increase.
- Cambridge Associates's biggest Q3 2026 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $105M.
- Cambridge Associates fully exited Vanguard Dividend Appreciation ETF in Q3 2026, selling an estimated $34.7M.
- Cambridge Associates's ten largest holdings make up 84% of its $6.78B portfolio in Q3 2026.
- Cambridge Associates opened 5 new positions and closed 5 in Q3 2026.
- Cambridge Associates's portfolio value fell 2.2% quarter-over-quarter to $6.78B.
Based on Cambridge Associates's 13F filing for Q3 2026, filed 13 Nov 2026.